Jonathan Golas
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
-
- Monoclonal and Polyclonal Antibodies Research 2
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Carolyn M. Discafani (3 shared papers)Allan Wissner (2 shared papers)Marvin F. Reich (2 shared papers)Hwei‐Ru Tsou (2 shared papers)Yu‐Fen Wang (2 shared papers)Sridhar K. Rabindran (2 shared papers)M. Brawner Floyd (2 shared papers)Ru Shen (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)Gastroenterology (1 paper)Molecular Cancer Therapeutics (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Jonathan Golas
9 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 59
- Oncology 663
- Pulmonary and Respiratory Medicine 243
- Cancer Research 78
- Organic Chemistry 184
- Radiology, Nuclear Medicine and Imaging 119
Countries citing papers authored by Jonathan Golas
This map shows the geographic impact of Jonathan Golas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Golas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Golas more than expected).
Fields of papers citing papers by Jonathan Golas
This network shows the impact of papers produced by Jonathan Golas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Golas. The network helps show where Jonathan Golas may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Golas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 558 | |
| 2 | 2005 | 272 | |
| 3 | 2017 | 176 | |
| 4 | 2005 | 123 | |
| 5 | 2019 | 102 | |
| 6 | 2020 | 84 | |
| 7 | 2020 | 48 | |
| 8 | 2017 | 37 | |
| 9 | 2021 | 10 |
About Jonathan Golas
Jonathan Golas is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Hepatology, Cancer Research and Cell Biology, having authored 9 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Synthesis and biological activity (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cancer Genomics and Diagnostics (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Caveolin-1 and cellular processes (1 paper). The work is most often cited by research in Oncology (663 citations), Pulmonary and Respiratory Medicine (243 citations), Cancer Research (78 citations), Organic Chemistry (184 citations) and Radiology, Nuclear Medicine and Imaging (119 citations). Jonathan Golas has collaborated with scholars based in United States. Frequent co-authors include Carolyn M. Discafani, Allan Wissner, Marvin F. Reich, Hwei‐Ru Tsou, Yu‐Fen Wang, Sridhar K. Rabindran, M. Brawner Floyd, Ru Shen, Bernard D. Johnson and Xiaoqing Shi. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Gastroenterology, Molecular Cancer Therapeutics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.